This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment of patients.

AIM ImmunoTech (AIM) announced that data were published on Roswell Park Comprehensive Cancer Center’s Phase 1 study evaluating AIM ImmunoTech’s drug Ampligen as a component of a chemokine ...